Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-31

Clinical Trial Update: Castleman Disease Collaborative Network Biobank

View source ↗

Summary

The Castleman Disease Collaborative Network Biobank clinical trial (NCT02871050) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Castleman Disease Collaborative Network | Conditions: Castleman Disease, Castleman's Disease | Status: WITHDRAWN